Paramount is making a hostile bid for Warner Bros. Discovery just days after Netflix reached a $72 billion deal with the ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company’s investigational RNA interference (RNAi) ...